Previous studies demonstrated that the overexpression of eIF3I interacted with and activated the oncogenic Akt1 by preventing the PP2A-mediated dephosphorylation of Akt-1 in human hepatocellular carcinoma [24]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.